https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2009-10-26 11:36:332016-11-28 12:36:57SuperGen and GSK to Collaborate on the Discovery and Development of Novel Epigenetic Therapeutics
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2009-09-21 12:37:072016-11-28 12:37:35David Bearss Resigns as Chief Scientific Officer to Join Huntsman Cancer Institute as Co-director of Center for Investigational Therapeutics
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2009-08-03 12:37:452016-11-28 12:38:15SuperGen’s MP-470 Demonstrates Clinical Benefit in Small Cell Lung Cancer and Neuroendocrine Tumor Patients
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2009-07-21 12:39:042016-11-28 12:39:29SuperGen Names Mohammad Azab, M.D., Chief Medical Officer
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2009-05-16 12:39:392016-11-28 12:40:02Astex reports positive data from its Phase I study of AT9283 at the ASCO Annual Meeting 2009
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2009-05-01 12:41:082016-11-28 12:41:40SuperGen Announces Departure of Chief Medical Officer
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2009-04-21 12:42:192016-11-28 12:42:40SuperGen Identifies New Class of Etk/Bmx Kinase Inhibitors
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
